Dr. Nivedita Patni

MD | Pediatric Endocrinology | Female

Dr. Nivedita Patni, MD is a Dallas, Texas based Pediatric doctor with medical specialization in Pediatric Endocrinology. Current practice location of Dr. Nivedita Patni is 5323 Harry Hines Blvd, Dallas, Texas - 75390-7208. She can be contacted on phone at 214-456-5959 and fax number 214-456-5963. Dr. Nivedita Patni is a sole proprietor of her business.
NPI number (Unique professional ID) for Dr. Nivedita Patni is 1508149741 which was assigned by NPPES on 23 Sep, 2011 and it was last updated on 09 Jul, 2018. Dr. Nivedita Patni license number is P5870 for Pediatrics Pediatric Endocrinology (2080P0205X) in Texas.
Dr. Nivedita Patni provides expert care to infants, children and adolescents who have diseases that result from an abnormality in the endocrine glands (glands which secrete hormones). These diseases include diabetes mellitus, growth failure, unusual size for age, early or late pubertal development, birth defects, the genital region and disorders of the thyroid, the adrenal and pituitary glands.
Complete Profile:
Dr. Nivedita Patni basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Endocrinology
Provider Name :Dr. Nivedita Patni
Credential :MD
Gender :Female
Business Address:
Dr. Nivedita Patni address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :5323 Harry Hines Blvd
Dallas, TX, 75390-7208
United States
Phone Number :214-456-5959
Fax Number :214-456-5963
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1508149741
NPI Entity Type : Individual
First Enrolment Date : 23 Sep, 2011
Last Updated On : 09 Jul, 2018
Medicare Participation:
Dr. Nivedita Patni participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :4385936657
Medicare Enrollment ID :I20160706002016
Primary Specialty :Pediatric Medicine
Medical School :Other
Graduation Year :2008
Accepts Medicare?Yes. Dr. Nivedita Patni accepts medicare insurance.
Group Practice Association:
Dr. Nivedita Patni is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Nivedita Patni is associated with along with the number of members in that group. She may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
University Of Texas Southwestern Medical Center064818825024955323 Harry Hines Blvd
Dallas, TX - 753907208
Ph: 2166480600
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Nivedita Patni are as mentioned. Primary taxonomy code for Dr. Nivedita Patni, MD is 2080P0205X (Pediatrics Pediatric Endocrinology).
Taxonomy Code SpecialityPrimaryLicense No.State
208000000XPediatricsNoTRN14873FL
2080P0205XPediatrics Pediatric EndocrinologyYesP5870TX
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :Po Box 845347
Dallas, TX, 75284-5347
United States
Phone Number :214-456-5959
Fax Number :214-456-5663
Business Location:
Patients can refer following map for directions to Dr. Nivedita Patni practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.